Towards clinical remission in psoriatic arthritis

The growing number of effective treatments for PsA resulted in new opportunities to improve outcome and quality of life of patients with PsA. However, aiming for better disease control and ultimately even clinical remission does not only require the availability of novel therapeutic options but also a better understanding of when and how to use them. Rather than starting from the therapeutics as such, this requires first of all a detailed understanding of the remaining unmet needs in clinical practice, followed by RCT and/or strategy trials to assess how to best address these unmet needs. Therefore, the overarching aim of this thesis is to investigate how we can achieve clinical remission in PsA.